Regulating Producers

"Regulating producers" generally refers to the laws and regulations that govern insurance producers, also known as insurance agents or brokers. Insurance producers are licensed professionals who help individuals and businesses navigate the insurance market and purchase insurance policies that meet their needs.

The regulation of insurance producers varies by state, but there are some common features across the United States. Key features of regulating producers include:

  • Licensing requirements: To become an insurance producer, an individual must typically pass a licensing exam and meet other requirements, such as completing pre-licensing education and passing a background check.

  • Continuing education: Many states require insurance producers to complete a certain number of hours of continuing education each year in order to maintain their license.

  • Ethical standards: Insurance producers are held to ethical standards that require them to act in the best interests of their clients and avoid conflicts of interest.

  • Disclosure requirements: Insurance producers are required to disclose certain information to their clients, such as their commission rates and any conflicts of interest that may arise.

  • Enforcement mechanisms: State insurance departments have the authority to investigate and discipline insurance producers who violate licensing or ethical standards.

The regulation of insurance producers can impact employee benefits in several ways. For example, it can help ensure that employees receive accurate information about their benefits options and that insurance producers are acting in the employees' best interests. It can also provide a mechanism for resolving disputes between employees and insurance producers or insurers.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.